sumitomo pharma earnings call：Investor Relations
Investor Relations
FY20241stQuarterFinancialResultsConferenceCall.Seemore·SpecialBriefingonthePressReleaseregardingPetroRabigh.Seemore·Understandingthe ...。其他文章還包含有：「PresentationWebcast」、「InvestorRelations(SecurityCode」、「FinancialResults」、「IRCalendar」、「ConferenceCallfor3rdQuarterofFY2022Financial...」、「Transcript:SumitomoPharmaCo.」、「Toshareholdersandinvestors」、「ConsolidatedFinancia...
查看更多 離開網站
PresentationWebcast
https://www.sumitomo-pharma.co
Financial results for FY2019 · May 14, 2020 Investors Meeting Presentation for FY2019（PDF/1,657KB） · Jan. 30, 2020 Q3 FY2019 Conference Call（PDF/1,386KB） · Nov ...
Investor Relations (Security Code
https://www.sumitomo-pharma.co
Posted Conference on Q1 FY2024 Financial Results [Webcast] · Sumitomo Pharma Announces Topline Results from Post-Marketing Clinical Study on TWYMEEG for the ...
Financial Results
https://www.sumitomo-pharma.co
Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2025 [IFRS]. Full Report（16pages）（PDF/209KB）.
IR Calendar
https://www.sumitomo-pharma.co
IR Calendar ; FY2023 · Jan. 31, 2024. 3rd Quarter of FY2023 financial results announcement ; FY2022 · Jan. 31, 2023. 3rd Quarter of FY2022 financial results ...
Conference Call for 3rd Quarter of FY2022 Financial ...
https://www.sumitomo-pharma.co
Conference Call for 3rd Quarter of FY2022 Financial Results Announcement ... in Sumitomo Pharma Food & Chemical Co., Ltd., assuming a closing by ...
Transcript : Sumitomo Pharma Co.
https://www.marketscreener.com
News Sumitomo Pharma Co., Ltd. Transcript : Sumitomo Pharma Co., Ltd., Q3 2024 Earnings Call, Jan 31, 2024.
To shareholders and investors
https://www.sumitomocorp.com
Useful information, including our businesses, financial results and future strategy, is presented here to provide you with an enhanced understanding of the ...
Consolidated Financial Results for the Year Ended March ...
https://www.sumitomo-pharma.co
Sumitomo Pharma Co., Ltd. (4506). Summary of Consolidated Financial Results for FY2023. 【Attachment Documents】. 1. Summary of Financial ...
Consolidated Financial Results for the Third Quarter of the ...
https://www.sumitomo-pharma.co
Core segment profit decreased owing to a decrease in gross profit on account of a revenue decline. Page 7. -4 -. Sumitomo Pharma Co., Ltd. (4506).